counterfeit semaglutide legal status fda ⚠️ CHICAGO CONSUMER ALERT: The has confirmed that versions of popular GLP-1 weight-loss drugs—including (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are Ozempic maker taking legal action
Description
Side Effect Profile Both medications have similar side effect profiles, with gastrointestinal issues being the most common: Nausea Diarrhea Vomiting Constipation Abdominal pain While the incidence of side effects is generally similar between the two medications, some studies suggest that tirzepatide may have a slightly higher rate of gastrointestinal side effects, particularly at higher doses

McGrath KH, Haller W, Bines JE
Diabetes Research and Clinical Practice , 199, 110634

Originally approved to help people with Type 2 diabetes, the class of medications known as GLP-1 agonists and dual GIP/GLP-1s quickly acquired a reputation for helping people shed stubborn pounds
